L063-0361 Screening compound: N-(4-methoxyphenyl)-5-[(1-methyl-2-oxo-2,3-dihydro-1H-indole-5-sulfonamido)methyl]-1,3,4-thiadiazole-2-carboxamide

L063-0361 Screening compound: N-(4-methoxyphenyl)-5-[(1-methyl-2-oxo-2,3-dihydro-1H-indole-5-sulfonamido)methyl]-1,3,4-thiadiazole-2-carboxamide
L063-0361 Screening compound: N-(4-methoxyphenyl)-5-[(1-methyl-2-oxo-2,3-dihydro-1H-indole-5-sulfonamido)methyl]-1,3,4-thiadiazole-2-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L063-0361
N-(4-methoxyphenyl)-5-[(1-methyl-2-oxo-2,3-dihydro-1H-indole-5-sulfonamido)methyl]-1,3,4-thiadiazole-2-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L063-0361

Molecular Formula

C20H19N5O5S2 (C20 H19 N5 O5 S2)

Compound Name

N-(4-methoxyphenyl)-5-[(1-methyl-2-oxo-2,3-dihydro-1H-indole-5-sulfonamido)methyl]-1,3,4-thiadiazole-2-carboxamide

IUPAC name

N-(4-methoxyphenyl)-5-[(1-methyl-2-oxo-23-dihydro-1H-indole-5-sulfonamido)methyl]-134-thiadiazole-2-carboxamide

SMILES

CN(C(C1)=O)c(cc2)c1cc2S(NCc1nnc(C(Nc(cc2)ccc2OC)=O)s1)(=O)=O

InChI

InChI=1S/C20H19N5O5S2/c1-25-16-8-7-15(9-12(16)10-18(25)26)32(28,29)21-11-17-23-24-20(31-17)19(27)22-13-3-5-14(30-2)6-4-13/h3-9,21H,10-11H2,1-2H3,(H,22,27)

InChI Key

DAXBVVFVKRUZBA-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD15117110

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

473.53

Hydrogen Bond Acceptors Count

12.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

1.805

Distribution Coefficient, logD

1.617

Water Solubility, LogSw

-2.82

Polar Surface Area

112.415

Acid Dissociation Constant (pKa)

7.67

Base Dissociation Constant (pKb)

-0.14

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

20.00

L063-0361 in Drug Discovery

Included in Screening Libraries

Antiviral Library (67538 compounds)

Hsp90-Targeted Library (11355 compounds)

Aurora A-B Kinases Targeted Library (9426 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Immune system
  • Cancer
  • Digestive system
  • Male
  • Female
  • Hemic and lymphatic
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with L063-0361 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L063-0361?
Check Price and Availability of L063-0361, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L063-0361 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L063-0361
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L063-0361
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L063-0361 available by request